• menu
    Market Place Market Place
    Sourcing support Sourcing Support
    API / FDF
    Excipients
    Services
    Developments
    News
    Market Intel
    #Phispers
    #SpeakPharma
    #LearnMore

    NEWS

    DRUGS & DEVELOPMENTS

    MARKET INTEL by PharmaCompass

    DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

    Enforcement Report - Week of August 23, 2023

    FDA

    Alembic, Aurobindo Pharma issue separate US drug recalls

    FIERCE PHARMA

    Enforcement Report - Week of June 7, 2023

    FDA

    Enforcement Report - Week of February 1, 2023

    FDA

    Enforcement Report - Week of January 25, 2023

    FDA

    ImprimisRx Launches Fortisite Compounded Antibiotic Formulation

    BUSINESSWIRE

    Mankind`s Generic Tobramycin Receives Approval in the U.S.

    FDA

    Enforcement Report - Week of June 15, 2022

    FDA

    Padagis Announces the FDA Approval and Launch of an AB Rated Generic Version of Tobradex® Ophthalmic Suspension

    PRESS RELEASE

    Padagis` Generic Tobramycin and Dexamethasone Receives Approval in the U.S.

    FDA

    Health Canada Issues Recall of Sterimax`s Tobramycin Injection USP 40mg/ml

    HEALTH CANADA

    7-day levofloxacin/dexamethasone eye drops as effective as standard

    NEWS-MEDICAL

    Sun Pharma`s Generic Deferasirox Receives Approval in US

    FDA

    Eyevance Pharmaceuticals Acquires TOBRADEX® ST and NATACYN®

    PR NEWSWIRE

    Mylan gains marketing authorization for TOBI Podhaler and TOBI Solution

    THE PHARMALETTER

    TEVA PHARMS USA Generic Tobramycin Receives Approval In US

    FDA

    Seven medicines leap closer to EU approval

    PHARMA TIMES

    Meeting highlights from the CHMP 10-13 December 2018

    Dr Reddys Labs Intl’s Generic Tobramycin Receives Approval in the US

    FDA

    Lupin launches generic antibiotic inhalation solution in US

    ECONOMIC TIMES

    Enforcement Report - Week of May 16, 2018

    FDA

    FDA Confirms Paragraph IV Patent Challenge of Bethkis (Tobramycin) Inhalation Solution

    FDA

    Mylan Pharm’s Generic Tobramycin Receives Approval In US

    FDA

    Somerset Theraps Generic Tobramycin Receives Approval In US

    FDA

    Lupin Atlantis Generic Tobramycin Receives Approval In US

    FDA

    Sun Pharma gets European Medicines Agency nod for Tobramycin

    ECONOMIC TIMES

    Warp Drive Bio Hands Over Antibiotics Program to Sanofi

    BIOSPACE

    Sanofi Partnership Passes First Test With Delivery of Antibiotic Compounds

    WALL STREET JOURNAL

    Claris gets USFDA nod for anti-bacterial infections injection

    ECONOMIC TIMES

    The relevance of solid state properties of aminoglycoside antibiotics

    PHARMA-EXCIPIENTS

    FDA Drug Shortages: Tobramycin Injection

    FDA

    Pari Pharma`s Vantobra (Tobramycin) Approved in Europe For RTI and Cystic Fibrosis

    EMA

    Walgreens Infusion Services, Ongoing Class II recall of Tobramycin various strengths in normal saline bags because of Lack of sterility assurance.

    FDA

    Pharmacy Creations, Ongoing Class I recall of Tropi/Cyclo/Phenyl/Tobra/Flurb (1/1/10/0.3/0.03)% Sterile Ophthalmic Solution, 1 mL Dropper in a 3 mL bottle, Rx only, Pharmacy Creations, Randolph, NJ 07869 (973) 328-8756. because of Non-Sterility: Failing sterility results were obtained from the recalling firm`s contract testing facility indicating that the products may not be sterile.

    Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.